Toll-like receptor (TLR) 2 is upregulated on peripheral blood monocytes of patients with psoriatic arthritis: A role for a gram-positive inflammatory trigger?

Clinical and Experimental Rheumatology

Volumn 29, Issue 6, 2011, Pages 958-962

  Carrasco, Solange ^a   Neves, Fabricio S ^b   Fonseca, Marcela H ^a   Gonçalves, Célio R ^a   Saad, Carta G ^a   Sampaio Barros, Percival D ^a   Goldenstein Schainberg, Cláudia ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

Author keywords

Innate immunity; Monocytes; Neutrophils; Psoriatic arthritis; Toll like receptors

Indexed keywords

TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4;

ADULT; ARTICLE; CLINICAL ARTICLE; DISEASE ACTIVITY; FEMALE; FLOW CYTOMETRY; GRAM POSITIVE INFECTION; HUMAN; INFLAMMATORY DISEASE; INNATE IMMUNITY; MALE; MONOCYTE; NEUTROPHIL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PSORIATIC ARTHRITIS;

ARTHRITIS, PSORIATIC; FEMALE; GRAM-POSITIVE BACTERIAL INFECTIONS; HEALTH STATUS; HUMANS; JOINTS; MALE; MIDDLE AGED; MONOCYTES; NEUTROPHILS; SEVERITY OF ILLNESS INDEX; STREPTOCOCCUS; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 4; UP-REGULATION;

EID: 84857620785     PISSN: 0392856X     EISSN: 1593098X     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. MOLL JM, HASLOCK I, MACRAE IF, WRIGHT V: Associations between ankylosing spondilitis, psoriatic arthritis, Reiter's disease, the intestinal arthropaties, and Behçet's syndrome. Medicine (Baltimore) 1974;53:343-64.
2. EKMAN P, KIRVESKARI J, GRANTORS K: Modification of disease outcome in Salmonella-infected patients by HLA-B27. Arthritis Rheum 2000;43:1527-34. (Pubitemid 30452472)
3. TAUROG JD, RICHARDSON JA, CROFT JT et al.: The germfree state prevents development of gut and joint inflammatory disease in HLA-B27 transgenic rats. J Exp Med 1994;180:2359-64. (Pubitemid 24351619)
4. BAETEN D, DEKEYSER F, VEYS E, MIELANTS H: Immune linkages between inflammatory bowel disease and spondyloarthropathies. Curr Opin Rheumatol 2002;14:342-7. (Pubitemid 34693975)
5. MEDZHITOV R, HURLBURT-PRESTON P, JANEWAY CA JR.: A human homologue of the Drosophila Toll protein signs activation of adaptive immunity. Nature 1997;388:394-7. (Pubitemid 27334820)
6. ROELOFS MF, ABDOLLAHI-ROODSAZ S, JOOSTEN LAB, VAN DEN BERG WB, RADSTAKE TRDJ: The orchestra of Toll-like receptor and their potential role in frequently occurring rheumatic conditions. Arthritis Rheum 2008;58:338-48. (Pubitemid 351294868)
7. LOTZ S, AGA E, WILDE I et al.: Highly purified lipoteichoic acid activates neutrophil granulocytes and delays their spontaneous apoptosis via CD14 and TLR2. J Leuk Biol 2004;75:467-77. (Pubitemid 38316378)
8. SCHRÖDER NWJ, MORATH S, ALEXANDER C et al.: Lipoteichoic Acid (LTA) of streptococcus pneumoniae and staphylococcus aureus activates immune cells via toll-like receptor (TLR)-2, lypopolysaccharide-binding protein (LBP), and CD 14, whereas TLR-4 and MD-2 are not involved. J Biol Chem 2003;278:15587-94. (Pubitemid 36799667)
9. VASEY FB, DEITZ C, FENSKE NA, GERMAIN BF, ESPINOZA LR: Possible involvement of group A streptococci in the pathogenesis of psoriatic arthritis. J Rheumatol 1982;9:719-22. (Pubitemid 13169964)
10. RANTAKOKKO K, RIMPILÄINEN M, UKSILA J, JANSÈN C, LUUKKAINEN R, TOIVANEN P: Antibodies to streptococcal cell wall in psoriatic arthritis and cutaneous psoriasis. Clin Exp Rheumatol 1997;15:399-404. (Pubitemid 27324002)
11. BEGON E, MICHEL L, BEATRICE F et al.: Expression, subcellular localization and cytokinic modulation of Toll-like receptors (TLRs) in normal human keratinocytes: TLR2 up-regulation in psoriatic skin. Eur J Dermatol 2007;17:497-506. (Pubitemid 350207160)
12. CANDIA L, MARQUEZ J, HERNANDEZ C, ZEA AH, ESPINOZA LR: Toll-like receptor-2 expression is upregulated in antigen-presenting cells from patients with psoriatic arthritis: a pathogenic role for innate immunity? J Rheumatol 2007;34:364-9.
13. TAYLOR W, GLADMAN D, HELLIWELL P, MARCHESONI A, MEASE P, MIELANTS H; CASPAR STUDY GROUP: Ossification criteria for psoriatic arthritis: development of a new criteria from a large international study. Arthritis Rheum 2006;54:2665-73. (Pubitemid 44205029)
14. PREVOO MLL, VAN'T HOFF MA, KUPER HH, VAN LEEUWEN MA, VAN de PUTTE LBA, VAN RIEL PLCM: Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective and longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 1995;38:44-8.
15. FRANSEN J, ANTONI C, MEASE PJ et al.: Performance of response criteria for assessing peripheral arthritis in patients with psoriatic arthritis: analysis of data from randomized controlled trials of two tumour necrosis factor inhibitors. Ann Rheum Dis 2006;65:1373-8. (Pubitemid 44620449)
16. IWAHASHI M, YAMAMURA M, AITA T et al.: Expression of Toll-like receptor 2 on CD 16+ blood monocytes and synovial tissue macrophages in rheumatoid arthritis. Arthritis Rheum 2002;46:298-308.
17. ZHANG X, GLOGAUER M, ZHU F, KIM TH, CHIU B, INMAN RD: Innate immunity and arthritis: neutrophil Rac and Toll-like receptor 4 expression define outcomes in infectiontriggered arthritis. Arthritis Rheum 2005;52:1297-304. (Pubitemid 40530140)
18. YAVUZ S, ELBIR Y, TULUNAY A, EKSIOGLU-DEMIRALP E, DIRESKENELI H: Differential expression of toll-like receptor 6 on granulocytes and monocytes implicates the role of microorganisms in Behçet's disease etiopathogenesis. Rheumatol Int 2008;28:401-6. (Pubitemid 351629487)
19. BAKER BS, OVIGNE JM, POWLES AV, CORCORAN S, FRY L: Normal keratinocytes express Tolllike receptors (TLRs) 1, 2 and 5: modulation of TLR expression in chronic plaque psoriasis. Br J Dermatol 2003;148:670-9. (Pubitemid 36629744)
20. DE RYCKE L, VANDOOREN B, KRUITHOF E, DE KEYSER F, VEYS EM, BAETEN D: Tumor necrosis factor a blockade treatment downmodulates the increased systemic and local expression of toll-like receptor 2 and toll-like receptor 4 in spondylarthropathy. Arthritis Rheum 2005;52:2146-58. (Pubitemid 40994338)
21. DE KEYSER F, ELEWAUT D, DE VOS M et al.: Bowel inflammation and the spondyloarthropathies. Rheum Dis Clin North Am 1998;24:785-813. (Pubitemid 28524024)